Microfluidics technology for nucleic acid formulations and bioanalysis has been widely used in the fields of drug formulation and bioanalysis. It facilitates the rapid screening of new drugs, optimization of the preparation process, and promotes the advancement of biomedical research and material science. Through this advanced technology, CD Formulation is dedicated to providing more efficient and reliable solutions for drug development and research.
Microfluidics is the precise manipulation of fluids in micro- and nanoscale spaces, enabling miniaturization to a few square centimeters on a chip for essential functions in biology, chemistry, and other laboratories. These functions include sample preparation, reactions, separations, and assays. The fundamental feature and greatest advantage of microfluidics lie in the flexible combination and scale integration of multiple unit technologies on an overall controllable tiny platform. The benefits of microfluidic technology in nucleic acid preparation are mainly evident in the following aspects.
Fig.1 Advantages of microfluidics technology. (CD Formulation)
CD Formulation offers microfluidic technologies that provide significant advantages in the field of nucleic acid formulation, enabling efficient and personalized nucleic acid drug development through precise control and diverse preparation pathways. We offer the following types of technologies.
Items | Descriptions |
---|---|
Microdroplet Microfluidics Technology | By forming and manipulating microdroplets in a microfluidic channel, each microdroplet can package and process various nucleic acid molecules. |
Continuous Flow Microfluidics Technology | Relying on the characteristics of laminar flow within the microfluidic channel, samples are separated and reacted along the channel based on their distinct physicochemical properties. |
Digital Microfluidics Technology | Precise manipulation of droplet movement, splitting, fusion, and mixing can be achieved through electrical wetting or other physical effects. |
Lab-on-a-Chip Technology Technology | Integrate multiple experimental steps, such as nucleic acid extraction, amplification, and detection, onto a microfluidic chip to achieve automation and integrated operation. |
Fig.2 Flow chart of nucleic acid formulation preparation. (CD Formulation)
Based on customer requirements and scientific principles, and combined with the latest microfluidic technology, design and develop a suitable microfluidic chip and control system.
Selection of suitable nucleic acid molecules (e.g., siRNA, mRNA, DNA, etc.) and other necessary raw materials (including buffers, protectants, encapsulation materials, etc.) is essential to ensure the biocompatibility and stability of the materials.
In microfluidic chips, homogeneous microdroplets are generated by precisely controlling the liquid flow rate and pressure. These microdroplets contain the desired nucleic acid formulation components.
After droplet generation, the microdroplets undergo further processing using the microfluidic technology platform. This includes mixing, separation, reaction, and cooling steps to ensure that each droplet meets the established quality standards.
Highly sophisticated testing equipment, such as high-resolution microscopy, mass spectrometry, and nuclear magnetic resonance (NMR), is used to fully characterize the generated microdroplets of nucleic acid formulations. This ensures that their size, consistency, encapsulation efficiency, and stability meet the expected requirements.
Microfluidic technology demonstrates a wide range of potential applications in the preparation of nucleic acid formulations. These formulations can be utilized to create various dosage forms to cater to different delivery modes and therapeutic requirements.
Technology: Preparation of drugs by microfluidic technology
Journal: Molecular Pharmaceutics
IF: 4.5
Published: 2020
Results:
Drug delivery systems (DDSs) have great potential to improve the treatment of a wide range of diseases, especially microbial infections and cancer. However, formulation procedures for DDSs remain challenging, especially at the nanoscale. Reducing batch-to-batch variation and increasing productivity are some of the fundamental requirements to accelerate the translation of DDSs from small-scale to industrialized levels. To address these issues, microfluidics has emerged as an alternative to traditional bench-scale methods. Through precise control of fluid flow and rapid mixing, microfluidic systems can be used to fabricate and design different types of DDSs with specific properties for efficient delivery of a wide range of drugs and genetic material. This review discusses the principles of controlled rapid mixing in different microfluidic strategies for the production of DDSs. In addition, the impact of microfluidic device design and parameters on the type and properties of DDS formulations is evaluated, and recent applications in drug and gene delivery are considered.
Fig.3 Microfluidics for the preparation of drug. (Tomeh M A, et al., 2020)
CD Formulation offers customized nucleic acid formulation solutions and has the flexibility to adjust microfluidic channel design and system parameters based on our customers' specific needs to achieve optimal preparation results. Contact us for our comprehensive one-stop service that covers the entire process from design and experimentation to large-scale production.
References